Stephen H. Willard's Insider Trades & SAST Disclosures
Stephen H. Willard's most recent trade in NRX Pharmaceuticals Inc was a trade of 50,000 Common Stock, par value $0.001 per share done at an average price of $1.2 . Disclosure was reported to the exchange on Dec. 16, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Stephen H. Willard.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NRX Pharmaceuticals Inc | Stephen H. Willard | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.17 per share. | 16 Dec 2022 | 50,000 | 50,000 | - | 1.2 | 58,500 | Common Stock, par value $0.001 per share |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges